West to Host Fourth Quarter and Full Year 2012 Conference Call
LIONVILLE, PA -- (MARKETWIRE) -- 02/13/13 --
West Pharmaceutical Services, Inc. (NYSE: WST) confirmed today that it will release fourth quarter and full year 2012 financial results before the market opens on Thursday, February 21, 2013 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 800-573-4840 (U.S.) or 617-224-4326 (International). The passcode is 15317330.
A live broadcast of the conference call will be available at the Company's web site, www.westpharma.com, in the "Investors" section. Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the Internet broadcast. Management will refer to a slide presentation during the call, which will be made available on the day of the call. To view the presentation, select "Presentations" in the "Investors" section of the Company's website. The presentation will be in "PDF" format and, if needed, the website includes a link to a free download of software that will enable viewing of the PDF presentation.
An online archive of the broadcast will be available at the site two hours after the live call and will be available through Thursday, February 28, 2013, by dialing 888-286-8010 (U.S.) or 617-801-6888 (International) and entering passcode 97318921.
West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.
Michael A. Anderson
Vice President and Treasurer
Investors and Financial Media:
John Woolford / Stefan Loren